(Q42651538)

4 November 2017

title

Suppression of oncogenic viral interferon regulatory factor (vIRF) of Kaposi's sarcoma-associated herpesvirus by ribozyme-mediated cleavage (English)

1 reference

4 November 2017

0 references

6

1 reference

4 November 2017

Zhang YJ

1

1 reference

4 November 2017

Wang XP

2

1 reference

4 November 2017

Deng JH

3

1 reference

4 November 2017

Salinas RA

4

1 reference

4 November 2017

Oishi N

5

1 reference

4 November 2017

publication date

1 April 2001

1 reference

4 November 2017

1 reference

4 November 2017

volume

8

1 reference

4 November 2017

issue

4

1 reference

4 November 2017

page(s)

285-293

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700299

4 November 2017

exact match

0 references

cites work

Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Interferon regulatory factors: the next generation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Selective reduction of c-myc mRNA in Daudi cells by human beta interferon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Simple RNA enzymes with new and highly specific endoribonuclease activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Hammerhead ribozyme specifically inhibits mutant K-ras mRNA of human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700299

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700299

1 reference

Dimensions Publication ID

4 November 2017

1033165767

0 references

1 reference